1 The effects of pretreatment with the thromboxane synthetase inhibitor UK 37248 (dazoxiben) administered 30 min before intravenous endotoxin (S. enteriditis) in the rat was investigated. 2 Plasma prostaglandins and thromboxanes were determined via radioimmunoassay. Endotoxaemia was associated with significant elevations above control values (<200pg/ml) in plasma thromboxane B2 (TXB2), prostaglandin E (PGE) and 6-keto-prostaglandin Fla (6-keto-PGFia). Within 30 min after endotoxin administration plasma immunoreactive (i) iTXB2 was 875±90pg/ml (n=9), iPGE was 1670±271 (n=9) and i6-keto-PGFia was 1191±209 pg/ml (n= 10). By 4 h plasma iTXB2 was 1743±328 pg/ml (n=5), iPGE was 2589±494pg/ml (n=9) and i6-keto-PGFia was 4251±984pg/ml (n=10). UK 37248 pretreatment resulted in a significant (P<0.001) decrease in plasma iTXB2 at 30min and 4h to 193±28pg/ml (n=5) and 421±57pg/ml (n=5), respectively. Unexpectedly UK 37248 also significantly decreased plasma i6-keto PGFia at 30 min and 4 h to 360±75 pg/ml (n= 10) (P<0.005) and 1920±513 pg/ml (n= 10) (P<0.05), respectively. iPGE plasma levels were not significantly changed in the UK 37248-pretreated rats 30 min (2210±370 pg/ml (n=9) or 4 h 3529± 1093 pg/ml (n= 13) after endotoxin compared to the vehicle-treated rats. 3 UK 37248 significantly (P<0.05) reduced the endotoxin mortality rate at 24 h from 69% (n= 13) to 30% (n= 13). UK 37248 also reduced splanchnic infarction from 90% (n = 20) to 6% (n = 16). 4 UK 37248 significantly improved the endotoxin-induced thrombocytopaenia, disseminated intravascular coagulation, hypoglycaemia and lysosomal labilization. 5 We conclude that UK 37248 provides significant beneficial effects in experimental endotoxic shock in the rat.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.